Hypertensive disorders of pregnancy (HDP) including preeclampsia occur in almost 10% of gestations. These women are known to have higher cardiovascular morbidity and mortality later in life in comparison with parous controls that had normotensive pregnancies. The pathophysiologic mechanisms linking preeclampsia (PE) and gestational hypertension (GH) to maternal CVD later in life are not well understood; however, several hypotheses have been proposed. Studies during pregnancy reported that the newly identified stage 1 hypertension in pregnancy was associated with increased risk of preeclampsia compared with normotensive women (39% versus 15%) (27). The United Nations Sustainable Development Goal (SDG) 3: Good health and Wellbeing aims to ensure healthy lives and promote well-being for all at all ages (3). Studies have shown that women with PE have a 12-fold increase in having a cardiovascular event. A meta-analysis demonstrated a 4.2-fold increased risk of heart failure, a 2.5-fold increased risk of coronary artery disease, and a 1.8-fold increased risk of stroke in women with preeclamptic pregnancies over a follow up period of up to 39 years (25,31). A possibility is that HDP and subsequent CVD share common predisposing risk factors and are both manifestations of the same pathophysiologic processes at different times in a woman’s life.  Pregnant women after delivery go back to society and only come back in contact with health care system once she develops hypertension or any cardiovascular event. Thus a very critical window period is lost where in modification of risk factors or prevention of complications can be as taken. There are various biomarkers which are used to predict severity of preeclampsia during antenatal period however very limited data is available after delivery in these women. Biomarkers and inflammatory markers sFlt, NLR, PLR, hCRP and ETCO is higher associated with the development and severity of preeclampsia so we aim to evaluate correlate noninvasive, inflammatory marker and biomarkers after delivery and correlate at risk of developing hypertension a precursor of CVD later in life.